Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy

ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)

Volume 16, 6 Issues, 2016

Download PDF Flyer

Current Gene Therapy

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 81st of 167 in Genetics & Heredity

Submit Abstracts Online Submit Manuscripts Online

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.542
5 - Year: 2.948

Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy

Current Gene Therapy, 14(2): 86-100.

Author(s): Balaji Balakrishnan and Giridhara R Jayandharan.

Affiliation: Department of Hematology & Centre for Stem Cell Research, Christian Medical College, Vellore-632004, Tamil Nadu, India.


Adeno-associated virus (AAV) based vectors have emerged as important tools for gene therapy in humans. The recent successes seen in Phase I/II clinical trials have also highlighted the issues related to the host and vector-related immune response that preclude the universal application of this promising vector system. A fundamental insight into the biological mechanisms by which AAV infects the host cell and a thorough understanding of the immediate and long-lived cellular responses to AAV infection is likely to offer clues and help design better intervention strategies to improve the therapeutic efficiency of AAV vectors. This article reviews the biology of AAV-host cellular interactions and outlines their application in the development of novel and improved AAV vector systems.


Adeno-associated virus, gene therapy, integration, serotype, viral vectors.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 2
First Page: 86
Last Page: 100
Page Count: 15
DOI: 10.2174/1566523214666140302193709

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science